Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpire Healthcare Regulatory News (SPI)

Share Price Information for Spire Healthcare (SPI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 248.00
Bid: 247.50
Ask: 248.00
Change: 2.50 (1.02%)
Spread: 0.50 (0.202%)
Open: 247.00
High: 248.00
Low: 247.00
Prev. Close: 245.50
SPI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

8 Oct 2018 15:54

RNS Number : 3329D
Spire Healthcare Group PLC
08 October 2018
 

8 October 2018

 

Spire Healthcare Group plc

 

Grant of 2018 Long Term Incentive Plan awards

Spire Healthcare Group plc (the "Company") announces that, on 8 October 2018, a performance share award (the "Award") was granted over the Company's ordinary shares in the form of nil cost options to the following Executive Director in the Company, under the rules of the Spire Healthcare Group plc Long Term Incentive Plan.

 

Name Maximum number of shares under Award

Jitesh Sodha 415,381

 

The number of shares set out above is the maximum number which may vest under the Award following the cessation of the performance period. The actual number of shares which vest will depend on the extent to which the following performance conditions have been satisfied.

 

The performance conditions applicable to the Award will be based as follows:

· 35% on relative total shareholder return (TSR) performance;

· 35% on adjusted earnings per share (EPS) performance; and

· 30% on two Operational Excellence measures.

 

Furher details of these performance conditions were disclosed in the 2017 Directors' Remuneration Report which was published in April.

 

The share price used to determine the number of shares under the Award was £1.4264 being the average of the middle market quotation over the last five dealing days ending on 5 October 2018.

 

The transaction place is London.

 

Name of contact and telephone number for queries:

Philip Davies 020 7427 9092

Deputy Company Secretary

 

The following disclosure is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

 

a)

Name

 

Jitesh Sodha

2

Reason for the notification

a)

Position/status

 

Chief Financial Officer and Executive Director

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

 

GB00BNLPYF73

b)

Nature of the transaction

Grant of performance share awards under the Company's Long Term Incentive Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

415,381

d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2018-10-08

f)

Place of the transaction

XLON

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBSBDGXUGBGII
Date   Source Headline
14th Oct 202210:00 amRNSChanges to Board of Directors and committees
3rd Oct 20224:04 pmRNSTotal Voting Rights
30th Sep 20227:00 amRNSBlock Listing Six Monthly Return
8th Sep 20227:00 amRNSInterim Results
1st Sep 20229:51 amRNSTotal Voting Rights
23rd Aug 20222:55 pmRNSHolding(s) in Company
15th Aug 20227:00 amRNSNotice of Interim Results
4th Aug 20222:11 pmRNSHolding(s) in Company
1st Aug 20222:43 pmRNSTotal Voting Rights
19th Jul 20229:07 amRNSBlock listing Interim Review
14th Jul 20223:48 pmRNSHolding(s) in Company
13th Jul 20224:43 pmRNSHolding(s) in Company
6th Jul 20224:00 pmRNSDirector/PDMR Shareholding
1st Jul 202210:28 amRNSTotal Voting Rights
29th Jun 20223:56 pmRNSHolding(s) in Company
29th Jun 20227:00 amRNSCapital Markets Event and new agreement with BUPA
1st Jun 20227:54 amRNSTotal Voting Rights
19th May 20227:44 amRNSHolding(s) in Company
18th May 20223:15 pmRNSHolding(s) in Company
13th May 202210:43 amRNSDirector/PDMR Shareholding
11th May 20224:25 pmRNSResult of AGM
11th May 20227:00 amRNSAGM Statement
6th May 20227:00 amRNSNotice of Capital Markets Day
3rd May 20228:46 amRNSTotal Voting Rights
27th Apr 20223:49 pmRNSDirector/PDMR Shareholding
6th Apr 20229:55 amRNSDirector/PDMR Shareholding
1st Apr 20224:40 pmRNS2021 Annual Report and 2022 Notice of AGM
1st Apr 202212:32 pmRNSHolding(s) in Company
1st Apr 202211:10 amRNSTotal Voting Rights
25th Mar 20222:51 pmRNSBlock listing application
24th Mar 20225:16 pmRNSHolding(s) in Company
16th Mar 20228:07 amRNSDirector/PDMR Shareholding
9th Mar 20227:43 amRNSHolding(s) in Company
4th Mar 20226:12 pmRNSHolding(s) in Company
4th Mar 20223:14 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSFinal Results
1st Mar 20227:23 amRNSTotal Voting Rights
25th Feb 202212:21 pmRNSHolding(s) in Company
25th Feb 20227:00 amRNSRe-financing of funding facilities
22nd Feb 20223:26 pmRNSHolding(s) in Company
22nd Feb 20221:38 pmRNSHolding(s) in Company
11th Feb 20227:00 amRNSManagement update
8th Feb 20227:00 amRNSNotice of Preliminary Results
1st Feb 20229:29 amRNSTotal Voting Rights
27th Jan 20222:57 pmRNSTotal Voting Rights
18th Jan 20227:00 amRNSUpdate on shareholder views
13th Jan 20224:52 pmRNSHolding(s) in Company
12th Jan 20222:40 pmRNSHolding(s) in Company
12th Jan 20222:38 pmRNSHolding(s) in Company
11th Jan 202210:14 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.